Analysts say pharma may escape near-term hit from Trump tariffs

Drug giants’ internal allocation of value – or “transfer pricing” – will be key to how hard the pharma sector is hit by Donald Trump’s expected tariffs, according to analysis from Bank of America Merrill Lynch. The sector is being closely watched in Ireland because it now accounts for the largest single category of goods shipped from here to the US and potentially 80,000 jobs could be at risk, according to the Irish Government..